Nucletron appoints Lamers as CEO as part of Delft buy-out

Nucletron has appointed Jos Lamers as its new CEO, which marks the next phase for the company following its management buy-out from Delft Instruments in August 2007.

Lamers has held senior management and board positions at Numico, an Amsterdam, Netherlands-based manufacturer of baby and infant food products, and currently is a member of the executive board at Eurofins Scientific, an international laboratory group offering quality testing and support services, according to the Veenendaal, Netherlands-based Nucletron.

With the appointment of Lamers as CEO, the managing board of Nucletron is complete, with Jeroen Cammeraat as chief operating officer and Jan Sigger as chief financial officer, according to the company. 

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.